Insiders Buy 80k Options as Humacyte Launches 47.6 M Share OfferingInsiders buy 80,000 options each as HUMACYTE’s IPO rolls out, signaling confidence amid volatile pricing and a push to fund Symvess® launches.HUMACYTE INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated DirectorDealingsBot 13/06/2026, 00:16 3 minutes to read
